ONCAlert | Upfront Therapy for mRCC
Lymphomas: Articles
Advances From the World Conference on Lung Cancer and New Developments in Relapsed Lymphoma and Immunotherapy
6:00 PM, Wed October 16, 2019
Pro Discusses Options for Patients With Advanced-Stage Hodgkin Lymphoma
6:00 PM, Thu October 10, 2019
Duvelisib Gains FDA Orphan Drug Designation for T-Cell Lymphomas
4:00 PM, Fri October 4, 2019
FDA Grants Fast Track Designation to Abexinostat for Fourth-Line Follicular Lymphoma
4:46 PM, Mon September 23, 2019
Experts Debate Best Strategies for Early-Relapsing Follicular Lymphoma
2:38 PM, Fri September 20, 2019
Improvement in PFS Shown With Checkpoint Inhibition Before Transplantation in R/R Hodgkin Lymphoma
6:30 PM, Fri September 13, 2019
Neelapu Discusses Toxicities Associated With CAR T Cells in Large B-Cell Lymphomas
7:00 PM, Thu August 29, 2019
FDA Grants Priority Review to Zanubrutinib for Previously Treated Mantle Cell Lymphoma
1:49 PM, Thu August 22, 2019
